Literature DB >> 6897635

The analgetic effects of an intrathecally administered partial opiate agonist, nalbuphine hydrochloride.

C Schmauss, C Doherty, T L Yaksh.   

Abstract

Nalbuphine (0.1-200 micrograms), unlike morphine (0.1-10 micrograms) administered intrathecally had no effect on the tail flick or hot plate response latencies. In contrast, both intrathecal nalbuphine and morphine inhibited, in a monotonic, dose dependent fashion, the writhing evoked by intraperitoneally administered acetic acid (ED50 = 38 nmol and 1.12 nmol, respectively.) The effects of intrathecal nalbuphine and morphine was antagonized by an equal dose of naloxone administered systemically. Co-intrathecal administration of morphine and nalbuphine revealed that a maximum inhibition of writhing could be obtained with low doses of either drug, while the effects of higher doses of either drug were attenuated as compared to the effects produced by the high dose of either drug alone. These data are consistent with the suggestion that nalbuphine exerts its agonistic effect through a mechanism that is pharmacologically distinct from that of morphine, and the likelihood of two populations of opioid receptors associated with the pain response evoked by thermal and visceral afferents, respectively is considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6897635     DOI: 10.1016/0014-2999(82)90389-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  14 in total

Review 1.  Opioid receptors and pain.

Authors:  R Dirksen
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

2.  Spinal antinociceptive actions and naloxone reversibility of intravenous mu- and kappa-opioids in spinalized rats: potency mismatch with values reported for spinal administration.

Authors:  C G Parsons; D C West; P M Headley
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

3.  A dose-response study of nalbuphine for post-thoracotomy epidural analgesia.

Authors:  A D Baxter; S Langanière; B Samson; I J McGilveray; K Hull
Journal:  Can J Anaesth       Date:  1991-03       Impact factor: 5.063

Review 4.  Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  J K Errick; R C Heel
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

5.  Epidural nalbuphine for analgesia following caesarean delivery: dose-response and effect of local anaesthetic choice.

Authors:  W R Camann; R H Hurley; L I Gilbertson; M L Long; S Datta
Journal:  Can J Anaesth       Date:  1991-09       Impact factor: 5.063

6.  A Novel Maintenance Therapeutic for Opioid Use Disorder.

Authors:  Beth Youngblood; Kevin Li; Donald R Gehlert; Julio C Medina; Neil Schwartz
Journal:  J Pharmacol Exp Ther       Date:  2021-05-19       Impact factor: 4.402

7.  Intrathecal nalbuphine as an adjuvant to subarachnoid block: What is the most effective dose?

Authors:  Arghya Mukherjee; Anirban Pal; Jitendra Agrawal; Amrita Mehrotra; Nidhi Dawar
Journal:  Anesth Essays Res       Date:  2011 Jul-Dec

8.  Epidural nalbuphine for postoperative analgesia in orthopedic surgery.

Authors:  Veena Chatrath; Joginder Pal Attri; Anju Bala; Ranjana Khetarpal; Deepti Ahuja; Sawinder Kaur
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec

9.  A Comparative Study for Post Operative Analgesia in the Emergency Laparotomies: Thoracic Epidural Ropivacaine with Nalbuphine and Ropivacaine with Butorphanol.

Authors:  Saravana Babu; Bikram Kumar Gupta; Gyanendra Kumar Gautam
Journal:  Anesth Essays Res       Date:  2017 Jan-Mar

10.  Postoperative Analgesia with Intrathecal Nalbuphine versus Intrathecal Fentanyl in Cesarean Section: A Double-Blind Randomized Comparative Study.

Authors:  Tripat Kaur Bindra; Parmod Kumar; Garima Jindal
Journal:  Anesth Essays Res       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.